logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10696611 B1

PDFFull Text
Date of Patent:
Jun. 30, 2020

Filed:

Aug. 24, 2015

Adamantane derivative compound

Applicant:

Amorepacific Corporation, Seoul, KR;

Inventors:

Yung Hyup Joo, Yongin-si, KR;

Song Seok Shin, Yongin-si, KR;

Byoung Young Woo, Yongin-si, KR;

Heung Soo Baek, Yongin-si, KR;

Yong Deog Hong, Yongin-si, KR;

Hong-Ju Shin, Yongin-si, KR;

Yeon Su Jeong, Yongin-si, KR;

Jon Hwan Lee, Yongin-si, KR;

Assignee:

AMOREPACIFIC CORPORATION, Seoul, KR;

Attorney:

Cantor Colburn LLP

Primary Examiner:

Shengjun Wang

Int. Cl.
CPC ...
C07C 239/00 (2006.01); C07D 453/02 (2006.01); C07D 413/00 (2006.01); A61K 31/16 (2006.01); C07C 13/615 (2006.01); C07C 233/59 (2006.01); A61K 31/167 (2006.01); A61K 8/42 (2006.01); C07C 233/60 (2006.01); A61K 8/49 (2006.01); A61Q 7/00 (2006.01); A61K 31/166 (2006.01); C07C 233/63 (2006.01); C07C 231/02 (2006.01); C07C 233/58 (2006.01); C07C 265/12 (2006.01); A61Q 19/00 (2006.01); C07D 263/56 (2006.01); C07C 15/04 (2006.01); C07C 233/57 (2006.01); A61K 31/4184 (2006.01);
U.S. Cl.
CPC ...
C07C 13/615 (2013.01); A61K 8/42 (2013.01); A61K 8/49 (2013.01); A61K 8/4973 (2013.01); A61K 31/166 (2013.01); A61K 31/167 (2013.01); A61Q 7/00 (2013.01); A61Q 19/008 (2013.01); C07C 15/04 (2013.01); C07C 231/02 (2013.01); C07C 233/57 (2013.01); C07C 233/58 (2013.01); C07C 233/59 (2013.01); C07C 233/60 (2013.01); C07C 233/63 (2013.01); C07C 265/12 (2013.01); C07D 263/56 (2013.01); A61K 31/4184 (2013.01); C07C 2603/74 (2017.05);
Abstract

Disclosed is a novel adamantine derivative compound, an isomer thereof, pharmaceutically acceptable salt thereof, prodrug thereof, hydrate thereof or a solvate thereof. Also disclosed is a method for preparing a novel adamantine derivative compound, an isomer thereof, pharmaceutically acceptable salt thereof, prodrug thereof, hydrate thereof or a solvate thereof. The novel adamantane derivative compound or the like has an excellent anti-androgenic effect.

Find Patent Forward Citations

Loading…